Drug Interactions between Cabenuva and Dovato
This report displays the potential drug interactions for the following 2 drugs:
- Cabenuva (cabotegravir/rilpivirine)
- Dovato (dolutegravir/lamivudine)
Interactions between your drugs
No interactions were found between Cabenuva and Dovato. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Cabenuva
A total of 459 drugs are known to interact with Cabenuva.
- Cabenuva is in the drug class antiviral combinations.
- Cabenuva is used to treat HIV Infection.
Dovato
A total of 207 drugs are known to interact with Dovato.
- Dovato is in the drug class antiviral combinations.
- Dovato is used to treat HIV Infection.
Drug and food interactions
rilpivirine food
Applies to: Cabenuva (cabotegravir / rilpivirine)
Food significantly increases the absorption of rilpivirine. You should take each dose of rilpivirine with a meal. Taking it on an empty stomach may lead to inadequate blood levels and reduced effectiveness of the medication. Grapefruit juice can also increase the absorption of rilpivirine and should preferably be avoided.
dolutegravir food
Applies to: Dovato (dolutegravir / lamivudine)
Information for this minor interaction is available on the professional version.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
Integrase strand transfer inhibitors
Therapeutic duplication
The recommended maximum number of medicines in the 'integrase strand transfer inhibitors' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'integrase strand transfer inhibitors' category:
- Cabenuva (cabotegravir/rilpivirine)
- Dovato (dolutegravir/lamivudine)
Note: In certain circumstances, the benefits of taking this combination of drugs may outweigh any risks. Always consult your healthcare provider before making changes to your medications or dosage.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.